ISCO First To Grow Human Corneal Tissue From Stem Cells, Entering Pre-Clinical Trials

Jeannine

Pioneer Founding member
ISCO First To Grow Human Corneal Tissue From Stem Cells, Entering Pre-Clinical Trials For Retinal Disease & Improved Forms of Corrective Laser Eye Surgery

January 30, 2009--StemCellPatents.com, an organization that covers recent news in stem cell therapeutics and has assembled the only comprehensive index of all issued U.S. stem cell patents, congratulates International Stem Cell Corporation (OTCBB: ISCO), on its recent developments, including being the first company to grow human corneal tissue from stem cells.

ISCO, the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, recently created layered human tissue from its parthenogenetic stem cells and transplanted this tissue into animals in pre-clinical trials to establish a potential new treatment for human retinal diseases, such as macular degeneration or retinitis pigmentosa. In related news, ISCO is planning pre-clinical trials aimed at applying corneal epithelial cells grown from human tissue to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery.

Continue reading here:
http://www.stemcellpatents.com/news-show-363#more
 
Top